The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy - Koster, J C; Cadario, F; Peruzzi, C; Colombo, C; Nichols, C G; Barbetti, F (J Clin Endocrinol Metab, 2008)
EK III